Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
144.3 USD | -0.28% | +1.97% | +22.12% |
05-09 | Crane NXT's Q1 Adjusted Earnings, Revenue Decline; 2024 Revenue Outlook Improved | MT |
05-08 | (CXT) CRANE NXT Sees Fiscal Year 2024 EPS Range $4.10 - $4.35 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.12% | 8.27B | |
+9.21% | 15.19B | |
-24.73% | 11.22B | |
+1.35% | 7.08B | |
+41.27% | 2.01B | |
+13.98% | 1.6B | |
+26.20% | 960M | |
+11.30% | 927M | |
+8.37% | 751M | |
-4.98% | 676M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- China Includes CR Double-Crane Pharmaceutical's Two Drugs in List of Insurance-Backed Drugs